---
title: "DRDGOLD Revamps Board Committees and Disbands Investment Committee Effective September 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295819045.md"
description: "DRDGOLD announced governance changes effective September 1, 2026, disbanding its Investment Committee and consolidating investment decisions at the full board level. The company reshaped board committees by appointing Mark Hoffman to Audit, Remuneration, and Social and Ethics committees, and Andrew Brady to Remuneration and Social and Ethics committees. These moves aim to strengthen oversight and accountability. Analyst ratings remain mixed, with a 'Buy' consensus at $35.00 target, while AI analysis rates DRD as Neutral."
datetime: "2026-08-13T14:57:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295819045.md)
  - [en](https://longbridge.com/en/news/295819045.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295819045.md)
generator: "portal-rs"
---

# DRDGOLD Revamps Board Committees and Disbands Investment Committee Effective September 2026

Drdgold ( (DRD) ) just unveiled an update.

On 13 August 2026, DRDGOLD announced governance changes that will take effect from 1 September 2026, including the disbandment of its Investment Committee, with all investment-related matters to be handled directly by the full board. The company also reshaped its board committee structure by appointing independent non-executive director Mark Hoffman to the Audit, Remuneration, and Social and Ethics committees, and non-executive director Andrew Brady to the Remuneration and Social and Ethics committees, moves the board says will strengthen its governance framework and oversight effectiveness for shareholders.

These adjustments signal a consolidation of strategic decision-making at board level while broadening key directors’ roles across critical oversight committees, potentially enhancing accountability and aligning the committee composition more closely with DRDGOLD’s evolving governance needs. The board maintains that the revised structure will better support its responsibilities in audit, remuneration, and social and ethics oversight as the company continues to refine its corporate governance practices.

The most recent analyst rating on (DRD) stock is a Buy  
 with a $35.00 price target.  
 To see the full list of analyst forecasts on Drdgold stock,  
 see the DRD Stock Forecast page. 

**Spark’s Take on DRD Stock**

According to Spark, TipRanks’ AI Analyst, DRD is a Neutral.

The score is driven primarily by strong financial performance (healthy margins, solid revenue growth, and minimal leverage), partially offset by cash flow conversion concerns. Technicals are the biggest near-term drag with a clear downtrend and bearish momentum. Valuation is supportive due to a moderate P/E and a 2.22% dividend yield.

To see Spark’s full report on DRD stock,  
 click here. 

**More about Drdgold**

DRDGOLD Limited is a South African gold producer focused on the recovery of gold from surface tailings, with its shares listed on the JSE, A2X and the NYSE under the ticker DRD. The company operates within the mining sector and caters primarily to investors seeking exposure to gold production and tailings retreatment operations in South Africa.

**Average Trading Volume:** 312,345

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $2.07B

Find detailed analytics on DRD stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [DRD.US](https://longbridge.com/en/quote/DRD.US.md)

## Related News & Research

- [DRDGOLD FY 2026 earnings preview](https://longbridge.com/en/news/296258286.md)
- [DRDGOLD Limited (NYSE:DRD) Declares $0.74 Dividend](https://longbridge.com/en/news/296494413.md)
- [DRDGOLD H2 Earnings Call Highlights](https://longbridge.com/en/news/296336237.md)
- [DRD: Revenue up 42%, operating profit up 83%, and 19th consecutive dividend declared](https://longbridge.com/en/news/296347732.md)
- [REG - Goldplat plc - Q4 Operating Results, Dividend Declaration & CFO](https://longbridge.com/en/news/296312804.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**